 According to the Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer deaths in the United States. This statistic exemplifies the need for researchers to develop more targeted therapeutic options. In the cover paper published in AncoTarget's Volume 12, Issue 24, researchers investigated important signaling pathways related to the colorectal cancer-promoting C.C. chemokine ligand 20. Read this study in more peer-reviewed oncology-focused research published by AncoTarget.